Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × sargramostim × Dermatologic × Clear all

Phase

Status

Completed 31 Withdrawn 5 Unknown 2 Recruiting 2 Terminated 1 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 2 talimogene laherparepvec 1 sargramostim 1 romiplostim 1 imisopasem manganese 1 gusacitinib 1 dabrafenib 1 cobimetinib 1 Propranolol 1 Paclitaxel 1 ON 01910 1 Microscopy, Confocal 1 Magnetic Resonance Spectroscopy 1 Curettage 1 CA-4948 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00278122 2013-12-10

Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

University of Virginia

Phase 2 Suspended

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡